Mark S. Levine, Chief Legal Officer at Immunovant, Inc. (IMVT), sold 2,633 shares at $16.29 ($43K) on 2023-04-25, disclosed to the SEC on 2023-04-26.
Open-market sale of $43k IMVT by Chief Legal Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| IMVT | SELL | 2024-10-18 | $165K | — | Filing → |
| IMVT | SELL | 2024-08-23 | $206K | — | Filing → |
| IMVT | SELL | 2024-07-26 | $223K | — | Filing → |